1. Home
  2. ICUI vs VCYT Comparison

ICUI vs VCYT Comparison

Compare ICUI & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$165.97

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Logo Veracyte Inc.

VCYT

Veracyte Inc.

HOLD

Current Price

$47.98

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICUI
VCYT
Founded
1984
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.2B
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
ICUI
VCYT
Price
$165.97
$47.98
Analyst Decision
Buy
Strong Buy
Analyst Count
8
12
Target Price
★ $193.38
$59.73
AVG Volume (30 Days)
193.4K
★ 1.1M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
100.62
★ 164.52
EPS
★ 1.96
0.66
Revenue
★ $2,231,262,000.00
N/A
Revenue This Year
N/A
$14.79
Revenue Next Year
$4.44
$11.13
P/E Ratio
$85.24
★ $72.71
Revenue Growth
N/A
★ N/A
52 Week Low
$113.37
$29.46
52 Week High
$192.85
$60.91

Technical Indicators

Market Signals
Indicator
ICUI
VCYT
Relative Strength Index (RSI) 55.69 59.38
Support Level $164.09 $46.04
Resistance Level $167.67 $49.46
Average True Range (ATR) 4.51 2.05
MACD 0.85 0.40
Stochastic Oscillator 86.13 85.15

Price Performance

Historical Comparison
ICUI
VCYT

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Share on Social Networks: